Skip to main content
Erschienen in: Translational Behavioral Medicine 2/2016

23.11.2015 | Practice and Public Health Policies

Society of Behavioral Medicine (SBM) position statement: SBM supports the National Colorectal Cancer Roundtable’s (NCCRT) call to action to reach 80 % colorectal cancer screening rates by 2018

verfasst von: Elizabeth A. Becker, PhD, MPH, Joanna Buscemi, PhD, Marian L. Fitzgibbon, PhD, Karriem Watson, MS, MPH, Kameron L. Matthews, MD, Robert A. Winn, MD, on behalf of the Society of Behavioral Medicine Health Policy Committee

Erschienen in: Translational Behavioral Medicine | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

The Society of Behavioral Medicine (SBM) urges stakeholders to support the National Colorectal Cancer Roundtable’s (NCCRT) initiative 80 % by 2018. Colorectal cancer (CRC) is largely preventable with early detection of pre-cancerous polyps but CRC screening is underutilized, especially among the underserved. In response to low screening rates, this initiative sets an important goal of a population screening rate of 80 % in adults ages 50 and older by the year 2018. It is estimated that this screening rate could prevent more than 20,000 CRC deaths per year within 15 years. The initiative takes a multilevel approach to improving screening rates and includes recommendations for clinicians, health care organizations, insurers, policymakers, and researchers.
Literatur
1.
Zurück zum Zitat Meester RGS, Doubeni CA, Zauber AG, et al. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015; 121(13): 2281-2285.CrossRefPubMedPubMedCentral Meester RGS, Doubeni CA, Zauber AG, et al. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015; 121(13): 2281-2285.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat American Cancer Society. Colorectal Cancer Facts & Figures 2014-2016. Atlanta: American Cancer Society; 2015. American Cancer Society. Colorectal Cancer Facts & Figures 2014-2016. Atlanta: American Cancer Society; 2015.
3.
Zurück zum Zitat Subramanian S, Klosterman M, Amonkar M, Hunt T. Adherence with colorectal cancer screening guidelines: a review. Prev Med. 2004; 38: 536-550.CrossRefPubMed Subramanian S, Klosterman M, Amonkar M, Hunt T. Adherence with colorectal cancer screening guidelines: a review. Prev Med. 2004; 38: 536-550.CrossRefPubMed
4.
Zurück zum Zitat Ahmed NU, Pelletier V, Winter K, Albatineh AN. Factors explaining racial/ethnic disparities in rates of physician recommendation for colorectal cancer screening. Am J Public Health. 2013; 103(7): e91-e99.CrossRefPubMedPubMedCentral Ahmed NU, Pelletier V, Winter K, Albatineh AN. Factors explaining racial/ethnic disparities in rates of physician recommendation for colorectal cancer screening. Am J Public Health. 2013; 103(7): e91-e99.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Ananthakrishnan A, Schellhase K, Sparapani R, Laud P, Neuner J. Disparities in colon cancer screening in the Medicare population. Arch Intern Med. 2007; 167(3): 258-264.CrossRefPubMed Ananthakrishnan A, Schellhase K, Sparapani R, Laud P, Neuner J. Disparities in colon cancer screening in the Medicare population. Arch Intern Med. 2007; 167(3): 258-264.CrossRefPubMed
6.
Zurück zum Zitat Cole AM, Jackson JE, Doescher M. Urban–rural disparities in colorectal cancer screening: cross-sectional analysis of 1998–2005 data from the Centers for Disease Control’s Behavioral Risk Factor Surveillance Study. Cancer Med. 2012; 1(3): 350-356.CrossRefPubMedPubMedCentral Cole AM, Jackson JE, Doescher M. Urban–rural disparities in colorectal cancer screening: cross-sectional analysis of 1998–2005 data from the Centers for Disease Control’s Behavioral Risk Factor Surveillance Study. Cancer Med. 2012; 1(3): 350-356.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat James TM. Disparities in colorectal cancer screening: a guideline-based analysis of adherence. Ethn Dis. 2006; 16(1): 228-233.PubMed James TM. Disparities in colorectal cancer screening: a guideline-based analysis of adherence. Ethn Dis. 2006; 16(1): 228-233.PubMed
8.
Zurück zum Zitat Becker EA, Griffith DM, West BT, Janz NK, Resnicow K, Morris AM. Potential biases introduced by conflating screening and diagnostic testing in colorectal cancer screening surveillance. Cancer Epidemiol Biomarkers Prev. 2015; 24(12): 1850-1854. Becker EA, Griffith DM, West BT, Janz NK, Resnicow K, Morris AM. Potential biases introduced by conflating screening and diagnostic testing in colorectal cancer screening surveillance. Cancer Epidemiol Biomarkers Prev. 2015; 24(12): 1850-1854.
Metadaten
Titel
Society of Behavioral Medicine (SBM) position statement: SBM supports the National Colorectal Cancer Roundtable’s (NCCRT) call to action to reach 80 % colorectal cancer screening rates by 2018
verfasst von
Elizabeth A. Becker, PhD, MPH
Joanna Buscemi, PhD
Marian L. Fitzgibbon, PhD
Karriem Watson, MS, MPH
Kameron L. Matthews, MD
Robert A. Winn, MD
on behalf of the Society of Behavioral Medicine Health Policy Committee
Publikationsdatum
23.11.2015
Verlag
Springer US
Erschienen in
Translational Behavioral Medicine / Ausgabe 2/2016
Print ISSN: 1869-6716
Elektronische ISSN: 1613-9860
DOI
https://doi.org/10.1007/s13142-015-0364-6

Weitere Artikel der Ausgabe 2/2016

Translational Behavioral Medicine 2/2016 Zur Ausgabe